| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/04/2009 | US20090143427 4-Oxoquinoline derivatives |
| 06/04/2009 | US20090143426 Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments |
| 06/04/2009 | US20090143425 Compounds affecting gap junction activity |
| 06/04/2009 | US20090143424 Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors |
| 06/04/2009 | US20090143423 Solid dispersion product containing n-aryl urea-based compound |
| 06/04/2009 | US20090143422 P38 inhibitors and methods of use thereof |
| 06/04/2009 | US20090143421 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 06/04/2009 | US20090143420 2-benzoylimidazopyridine derivatives, preparation and therapeutic use thereof |
| 06/04/2009 | US20090143418 Compositions and Methods for Preventing and Treating Hair Growth Cycle-Related Conditions |
| 06/04/2009 | US20090143417 Methods of treating pain |
| 06/04/2009 | US20090143416 Method of Inducing Tolerance of Plants Against Bacterioses |
| 06/04/2009 | US20090143415 Tetrodotoxin And Its Derivatives For The Treatment Of Central-Nervously Derived Neuropathic Pain |
| 06/04/2009 | US20090143414 Quinazoline Derivatives Having Tyrosine Kinase Inhibitory Activity |
| 06/04/2009 | US20090143413 Thiazole Derivatives as CXCR3 Receptor Modulators |
| 06/04/2009 | US20090143412 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 06/04/2009 | US20090143411 Thiophens and Their Use as Anti-Tumor Agents |
| 06/04/2009 | US20090143409 3-pyridinecarboxamide derivatives as hdl-cholesterol raising agents |
| 06/04/2009 | US20090143408 Compositions and methods for inhibiting cytochrome p450 2d6 |
| 06/04/2009 | US20090143407 Alzheimer's disease; gamma-aminobutyric acid inhibitors; 5-(5-methyl-3-phenyl-isoxazol-4-ylmethoxy)-pyrazine-2-carboxylic acid methyl ester |
| 06/04/2009 | US20090143406 New Phenylpiperazine |
| 06/04/2009 | US20090143405 1-{[1-(2,6-dimethylphenyl)-1H-tetrazol-5-yl]phenylmethyl}-4-(3-phenylallyl)piperazine; G-protein coupled receptor antagonist; antidepressant, anxiolitic agent, obesity |
| 06/04/2009 | US20090143404 Pharmaceutical composition |
| 06/04/2009 | US20090143403 Methods for Administering Aripiprazole |
| 06/04/2009 | US20090143402 Isoquinolinone derivatives as nk3 antagonists |
| 06/04/2009 | US20090143401 Pyridine and Pyrimidine Derivatives as Inhibitors of Histone Deacetylase |
| 06/04/2009 | US20090143400 Purine derivatives having immuno-modulating properties |
| 06/04/2009 | US20090143399 Protein Kinase Inhibitors |
| 06/04/2009 | US20090143398 trans-N-(4-{2-[4-(5,6-dichloro-2-methylamino-pyrimidin-4-yl)-piperazin-1-yl]-ethyl]-cyclohexyl}-acetamide; for treating Parkinson's disease; reacting trans-(4-{4-[2-(4-amino-cyclohexyl)-ethyl]-piperazin-1-yl}-5,6-dichloro-pyrimidin-2-yl)-methyl-amine trihydrochloride with acetyl chloride |
| 06/04/2009 | US20090143397 Catechol-based derivatives for treating or preventing diabetics |
| 06/04/2009 | US20090143396 Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors |
| 06/04/2009 | US20090143395 Piperazine Derivatives |
| 06/04/2009 | US20090143394 Compounds for activating tgf-beta signaling |
| 06/04/2009 | US20090143393 Method of stimulating hair growth |
| 06/04/2009 | US20090143392 Methods of Treating Obesity and Metabolic Disorders |
| 06/04/2009 | US20090143391 Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | US20090143390 Parenteral Formulations of Dopamine Agonists |
| 06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2009 | US20090143388 Treatment of brain disorders |
| 06/04/2009 | US20090143387 Sustained-release tablet composition |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143385 Isoxazolo-pyridazine derivatives |
| 06/04/2009 | US20090143384 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 06/04/2009 | US20090143383 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 06/04/2009 | US20090143382 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 06/04/2009 | US20090143381 Modulators of atp-binding cassette-transporters |
| 06/04/2009 | US20090143380 2h- or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof |
| 06/04/2009 | US20090143379 Storage stable perfusion solution for dihydropteridinones |
| 06/04/2009 | US20090143378 Thienopyrimidine and thienopyridine kinase modulators |
| 06/04/2009 | US20090143377 Methods and compositions for treating disorders |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents |
| 06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
| 06/04/2009 | US20090143373 Quinolone carboxylic acid-substituted rifamycin derivatives |
| 06/04/2009 | US20090143372 Chemical compounds |
| 06/04/2009 | US20090143371 Isoxazole-pyridine derivatives |
| 06/04/2009 | US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors |
| 06/04/2009 | US20090143369 Methods of using substituted morpholine and thiomorpholine derivatives |
| 06/04/2009 | US20090143368 Use of Cinnamoyl Compound |
| 06/04/2009 | US20090143367 8-chloro-3,4-dimethyl-1-(2- methylphenyl)imidazo[1,5- a]quinoxaline; inhibitors of phosphodiesterase 10; for treatment of central nervous system disorders (cognitive deficits, social phobia, reduced vigilance, obesity and psychosis) |
| 06/04/2009 | US20090143366 Chemical compounds |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | US20090143364 Chiral cis-imidazolines |
| 06/04/2009 | US20090143363 Deuterated lorcaserin |
| 06/04/2009 | US20090143362 Carbamazepine formulations |
| 06/04/2009 | US20090143361 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 |
| 06/04/2009 | US20090143360 Oxcarbazepine Formulation |
| 06/04/2009 | US20090143359 Percutaneously Absorptive Ophthalmic Preparation Comprising Epinastine |
| 06/04/2009 | US20090143358 Inhibitors of ion channels |
| 06/04/2009 | US20090143357 Heteroaryl urea derivatives useful for inhibiting chk1 |
| 06/04/2009 | US20090143356 Polycylclic Carbamoylpyridone Derivative Having HIV Integrase Inhibitory Acitvity |
| 06/04/2009 | US20090143355 Substituted aryl-amine derivatives and methods of use |
| 06/04/2009 | US20090143354 P2X7 Receptor Antagonists and Their Use |
| 06/04/2009 | US20090143353 Antifungal bicyclic hetero ring compounds |
| 06/04/2009 | US20090143352 Pyrrolo-pyridine kinase modulatiors |
| 06/04/2009 | US20090143351 Substituted azetidinones |
| 06/04/2009 | US20090143350 Anxiolytic Marcgraviaceae Compositions Containing Betulinic Acid, Betulinic Acid Derivatives, and Methods |
| 06/04/2009 | US20090143349 Steroid tetrol solid state forms |
| 06/04/2009 | US20090143348 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 06/04/2009 | US20090143347 Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases |
| 06/04/2009 | US20090143346 Method for synthesizing furanosteroids |
| 06/04/2009 | US20090143345 Thioamide derivatives as progesterone receptor modulators |
| 06/04/2009 | US20090143344 Methods for treating or preventing symptoms of hormonal variations |
| 06/04/2009 | US20090143343 Compositions for the treatment of inflammation of the gastrointestinal tract |
| 06/04/2009 | US20090143342 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
| 06/04/2009 | US20090143340 Pyrocatechin Derivatives |
| 06/04/2009 | US20090143339 Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels |
| 06/04/2009 | US20090143338 Metal coordinated compositions |
| 06/04/2009 | US20090143337 C2-C5-Alkyl-Imidazole-Bisphosphonates |
| 06/04/2009 | US20090143336 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 06/04/2009 | US20090143335 Modified absorption formulation of gaboxadol |
| 06/04/2009 | US20090143334 Method of Protecting Wood Through Enhanced Penetration of Wood Preservatives and a Related Solution |
| 06/04/2009 | US20090143333 Silicone gel-based compositions for wound healing and scar reduction |
| 06/04/2009 | US20090143332 Cyclodextrin Cyanohydrins |
| 06/04/2009 | US20090143331 Polysaccharide gel formulation having increased longevity |
| 06/04/2009 | US20090143330 Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate |
| 06/04/2009 | US20090143329 Gip secretion inhibitor |
| 06/04/2009 | US20090143328 Method of Treating Cancer by Administration of Topical Active Corticosteroids |
| 06/04/2009 | US20090143327 General composition framework for ligand-controlled regulatory systems |
| 06/04/2009 | US20090143326 MICROMIRs |
| 06/04/2009 | US20090143325 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN AND INTERLEUKIN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |